Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
3.850
+0.010 (0.26%)
Sep 18, 2026, 4:08 PM HKT
HKG:2591 Revenue
Guangzhou Innogen Pharmaceutical Group had revenue of 78.22M CNY in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 153.28M, up 171.55% year-over-year. In the year 2025, Guangzhou Innogen Pharmaceutical Group had annual revenue of 131.51M.
Revenue (ttm)
153.28M CNY
Revenue Growth
+171.55%
P/S Ratio
9.94
Revenue / Employee
1.49M CNY
Employees
103
Market Cap
1.76B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.51M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.